G

Researcher Profile

GILLES R DAGENAIS

4

Publications

4,197

Citations

10

Co-Authors

3

Active Years

Publications

Journal Article The Lancet Sep 01, 2021

Fixed-dose combination therapies with and without aspirin for primary prevention of cardiovascular disease: an individual participant data meta-analysis

Philip Joseph · Gholamreza Roshandel · Peggy Gao · Prem Pais +21 more

10.1016/s0140-6736(21)01827-4 137 citations

Journal Article The Lancet Jul 01, 2019

Dulaglutide and cardiovascular outcomes in type 2 diabetes (REWIND): a double-blind, randomised placebo-controlled trial

Hertzel C Gerstein · Helen M Colhoun · GILLES R DAGENAIS · Rafael Diaz +1451 more

10.1016/s0140-6736(19)31149-3 2,422 citations

Open Access Journal Article The Lancet Global Health Oct 01, 2019

World Health Organization cardiovascular disease risk charts: revised models to estimate risk in 21 global regions

Stephen Kaptoge · Lisa Pennells · Dirk De Bacquer · Marie Therese Cooney +97 more

10.1016/s2214-109x(19)30318-3 892 citations

Open Access Journal Article The Lancet Jan 01, 2018

Rivaroxaban with or without aspirin in patients with stable peripheral or carotid artery disease: an international, randomised, double-blind, placebo-controlled trial

Sonia S Anand · Jackie Bosch · John W Eikelboom · Stuart J Connolly +634 more

10.1016/s0140-6736(17)32409-1 746 citations

Publication Timeline

2021

1

2019

2

2018

1

Frequent Co-Authors

Patricio Lopez-Jaramillo

EDUARDO HASBANI

David Colquhoun

PRAVINSAGAR MEHTA